Several of the events took place at ‘upscale restaurants’ in San Francisco, at costs of up to $163 per person, according to ...

The five ‘Stans’, independent nations since 1991, are influenced by their neighbours, but distinctive and fascinating.

Gilead Sciences has made yet another rush into the oncology category, licensing a bispecific antibody from MacroGenics in development as a treatment for CD123-positive blood cancers, including ...

Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously ...

Review quarterly and annual revenue, net income, and cash flow for Gilead Sciences Inc (GILD:XNAS) stock through the last fiscal year.

Review the current valuation for Gilead Sciences Inc (GILD:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.